Clinical Trial: Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Brief Summary: Study objective is to evaluate the level of control of hypercholesterolemia in Egypt in patients taking lipid lowering agents for at least 3 months ( with no drug change or dose amendment for a minimum of 6 weeks).
Detailed Summary: Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Sponsor: AstraZeneca
Current Primary Outcome: The proportion of patients on lipid-lowering treatment reaching the LDL-C goals according to the NCEP ATP III/ updated 2004 NCEP ATP III , overall and by country [ Time Frame: 24 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- The proportion of patients on lipid-lowering treatment reaching the LDL-C goals according to the NCEP ATP III/ updated 2004 NCEP ATP III , in the following sub-populations: - primary/secondary prevention patients and with metabolic syndromes [ Time Frame: 24 weeks ]
- The proportion of patients on lipid-lowering treatment reaching the LDL-C goals according to the Third Joint European Task Force guideline, in the following sub-populations: - primary/secondary prevention patients and with metabolic syndromes [ Time Frame: 24 weeks ]
- Determinants (e.g. patient and physician characteristics , country-specific guidelines or recommendations) for undertreatment of hypercholesterolemia [ Time Frame: 24 weeks ]
- Physician characteristics associated with the allocation of treatment regimen. [ Time Frame: 24 weeks ]
- The proportion of patients on lipid-lowering treatment reaching the non HDL-C goals according to the NCEP ATP III/ updated 2004 NCEP ATP III , in the sub-population patients with fasting triglycerides<200 mg/d [ Time Frame: 24 weeks ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: December 2, 2009
Date Started: November 2009
Date Completion:
Last Updated: May 23, 2012
Last Verified: May 2012